Diagnostic Microbiology and Infectious Disease
BacteriologyFour-year prospective evaluation of community-acquired bacteremia: epidemiology, microbiology, and patient outcome
Introduction
Over 250,000 patients in the United States develop bacteremia or fungemia each year, with an associated mortality of 20 to 50% per episode Reimer et al 1997, Weinstein et al 1983a, Weinstein et al 1997. Septicemia is now the twelfth leading cause of death in the United States (Anonymous, 1998). Though many recent studies of nosocomial bacteremia have been reported, there are limited data focusing on community-acquired bacteremia (Mylotte et al., 2001).
Given the morbidity, mortality, and economic consequences of community-acquired bacteremia, we decided to better describe this important clinical problem. We thus provide a detailed and comprehensive analysis of community-acquired bacteremia occurring at a single institution over a recent four-year period. Our objectives in studying community-acquired bacteremia were to: 1) describe their epidemiologic and microbiologic characteristics; 2) determine the crude mortality and investigate the effect of selected factors on mortality; and 3) identify independent predictors of mortality.
Section snippets
Setting
This prospective study was conducted at the Seattle Division of the Veterans Affairs Puget Sound Healthcare System (VAPSHS) from January 1, 1994 to December 31, 1997. The VAPSHS is a 250-bed teaching hospital in Seattle, Washington, affiliated with the University of Washington School of Medicine.
Methods
We extracted data on all episodes of community-acquired bacteremia and fungemia occurring among patients admitted to the Seattle Division of the VAPSHS during the study period. All positive blood
Epidemiology
During the four-year study period, 387 episodes of community-acquired bacteremia were documented in 334 patients. The mean age of patients with community-acquired bacteremia was 62 years (range, 21–100), and the median length of hospital stay was nine days (range, 1–300). Comorbid conditions were frequent; 22% of episodes occurred in patients with diabetes mellitus, 21% in patients with renal failure, 21% in patients with a malignancy, and 13% in patients with COPD. In addition, 10% of episodes
Discussion
In our study of community-acquired bacteremias among patients admitted to a single institution over a four-year period, S. aureus was the leading pathogen and caused almost one-quarter of episodes. These findings are consistent with those of Weinstein and colleagues in a recent review (Weinstein et al., 1997), but differ from the results of their earlier study in 1975–77 (Weinstein et al., 1983a). At that time, the leading pathogens were E. coli and S. pneumoniae, with S. aureus identified as
Acknowledgments
We are indebted to Larry G. Carlson, MS, and Paul Baker, ARNP, for data support, and to the VA Epidemiologic Research and Information Center (ERIC), Seattle, for providing overall logistic support. This project was supported by a Department of Veterans Affairs research grant (EPP-97–015) awarded to Drs. Lipsky and Saint.
References (18)
- et al.
Polymicrobial sepsisanalysis of 184 cases using log linear models
American Journal of the Medical Sciences
(1980) - et al.
Community-acquired bacteremia at a teaching versus a nonteaching hospitalimpact of acute severity of illness on 30-day mortality
American Journal of Infection Control
(2001) - et al.
The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infectiona meta-analysis
American Journal of Medicine
(1998) - et al.
Pneumococcal bacteremia in three community teaching hospitals from 1980 to 1989
Chest
(1993) - Anonymous. (1996). Defining the public health impact of drug-resistant Streptococcus pneumoniae: report of a working...
- Anonymous. (1998). Births, marriages, divorces and deaths for 1997 (Cen-ters for Disease control and Prevention,...
The pneumococcus at the milleniumnot down, not out
Journal of Infectious Diseases
(1999)- et al.
Survey of bloodstream infections due to gram-negative bacillifrequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997
Clinical Infectious Diseases
(1999) - et al.
The adaptive value of fever
Cited by (71)
Gram-negative bacteremia: Which empirical antibiotic therapy?
2014, Medecine et Maladies InfectieusesCitation Excerpt :The unexpectedly high prevalence of P. aeruginosa strains (10.5% of all strains and 61.5% of cefotaxime-resistant strains) should be compared to other reports. Lark et al. reported a 7.4% prevalence of P. aeruginosa in CA-GNB patients in 2001; and Schechner et al. reported a 6.8% prevalence in 2009 [19,20], whereas the authors of a French retrospective multicenter study collecting blood cultures from 1998 to 2003 reported only 3.5% of P. aeruginosa strains [21]. Our result could be explained by the frequency of health care-associated infection in our study population.
Clinical characteristics and outcomes of community-onset acute pyelonephritis caused by Escherichia coli in elderly patients
2014, European Geriatric MedicineThe clinical and prognostic importance of positive blood cultures in adults
2010, American Journal of MedicineCitation Excerpt :A similar relationship also was seen between increasing number of predisposing comorbid conditions and attributable mortality (Figure 2). Studies over the past 4 decades have documented both recurrent findings and evolving changes in the microbiology, epidemiology, and outcomes of adult bloodstream infections.1-9 Compared with the 2 similarly designed studies that were performed by members of our group, S. aureus and E. coli remain the most frequently isolated bloodstream pathogens.1-3
Escherichia coli bacteraemia in adults: Age-related differences in clinical and bacteriological characteristics, and outcome
2014, Epidemiology and Infection